Home › Funds › Deep Track Capital, LP › GMAB
Deep Track Capital, LP position in GMAB
GENMAB A/S · Health Care
Deep Track Capital, LP reported holding 3,000,000 shares of GMAB (GENMAB A/S) in its Q2 2026 13F filing — a position valued at US$82.4M, representing 1.23% of its reported portfolio and ranking #30 among its reported holdings. Deep Track Capital, LP has disclosed GMAB holdings in 4 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Deep Track Capital, LP's GMAB position evolved
Deep Track Capital, LP first disclosed a stake in GMAB in Q4 2024 at 2,000,000 shares (US$41.7M). The position peaked in Q1 2026 at 3,663,250 shares, worth US$98.3M. Across 4 filings, Deep Track Capital, LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 3,000,000 shares valued at US$82.4M — a reduction of -663,250 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 2.00M | $41.74M | New |
| Q3 2025 | 481.27K | $14.76M | New |
| Q1 2026 | 3.66M | $98.28M | New |
| Q2 2026 | 3.00M | $82.41M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GMAB and 13F data
GMAB (GENMAB A/S) is a Health Care company. 30 other funds we track also report a position in GMAB — the largest reported positions include Paradigm Biocapital Advisors LP (US$360.8M), Orbis Allan Gray Ltd (US$312.3M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$188.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GMAB
- Paradigm Biocapital Advisors LP 13.13M sh · $360.77M · Q2 2026
- Orbis Allan Gray Ltd 11.37M sh · $312.28M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 6.87M sh · $188.58M · Q2 2026
- Sofinnova Investments, Inc. 4.05M sh · $111.12M · Q2 2026
- HARDING LOEVNER LP 3.09M sh · $86.90M · Q2 2026
More on Deep Track Capital, LP
FAQ
How long has Deep Track Capital, LP held GMAB?
Deep Track Capital, LP has disclosed GMAB holdings in 4 of the last 7 reported quarters, going back to Q4 2024.
What is Deep Track Capital, LP's current position in GMAB?
As of Q2 2026, Deep Track Capital, LP holds 3.00M shares of GMAB (GENMAB A/S), valued at $82.41M, representing 1.23% of its reported portfolio and ranking #30.
Has Deep Track Capital, LP been buying or selling GMAB?
In the latest 13F filing (Q2 2026), Deep Track Capital, LP reduced its position in GMAB. The position peaked in Q1 2026 at 3.66M shares.
Which other funds hold GMAB?
Other major institutional holders of GMAB include Paradigm Biocapital Advisors LP, Orbis Allan Gray Ltd, DEERFIELD MANAGEMENT COMPANY, L.P., among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.